RETRACTED ARTICLE: Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways
Hepatic stellate cell
CCL4
Decoction
Hepatic fibrosis
DOI:
10.1186/s12906-015-0733-1
Publication Date:
2015-06-29T10:18:30Z
AUTHORS (7)
ABSTRACT
Hepatic stellate cell (HSC) activation is activated mainly by endotoxin and transforming growth factor (TGF-β1) in chronic liver injury, consequently, can be important therapeutic targets. Xia-yu-xue decoction (XYXD), a classical recipe used China to treat fibrosis, has been revealed inhibit hepatic fibrosis animal models, the mechanism of action XYXD remains elusive. In present study, we evaluated whether reduced pro-fibrogenic pathways induced lipopolysaccharide (LPS) TGF-β1 HSCs.The vivo effect on progression was assessed mice model carbon tetrachloride (CCl4), The vitro GFP-Col-HSC cells using LPS stimulation.XYXD treatment CCl4-induced decreased hydroxyproline (Hyp) content, mRNA levels smooth muscle actin (α-SMA) Col 1(α1) fibrotic liver. suppressed nuclear factor-κB (NF-κB) NF-κB-luciferase reporter. expression NF-κB target genes, chemokine (C-C motif) ligand 2 (CCL2) (C-X-C (CXCL2) after treatment. targets Col1(α1) tissue inhibitor metalloproteinases (TIMP1) treatment.XYXD attenuates inhibiting HSC via inhibition signaling pathway, thereby blocking synthesis Col1 (α1) TIMP-1. These findings from study suggest that may for which are thought take part.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (27)
CITATIONS (15)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....